Abundance Wealth Counselors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,007
Closed -$204K 253
2025
Q4
$204K Sell
4,007
-786
-16% -$40.2K 0.03% 158
2025
Q3
$266K Buy
4,793
+662
+16% +$38.8K 0.05% 140
2025
Q2
$285K Sell
4,131
-212
-5% -$14.4K 0.05% 140
2025
Q1
$302K Buy
4,343
+55
+1% +$4.54K 0.06% 131
2024
Q4
$369K Buy
4,288
+541
+14% +$58.5K 0.08% 120
2024
Q3
$446K Buy
+3,747
New +$500K 0.09% 118
2024
Q2
Sell
-3,813
Closed -$490K 124
2024
Q1
$490K Buy
3,813
+451
+13% +$53.7K 0.11% 106
2023
Q4
$348K Sell
3,362
-114
-3% -$11.3K 0.09% 113
2023
Q3
$316K Buy
+3,476
New +$306K 0.09% 108
2023
Q2
Sell
-4,540
Closed -$361K 120
2023
Q1
$361K Sell
4,540
-98
-2% -$6.95K 0.09% 112
2022
Q4
$314K Sell
4,638
-278
-6% -$16.3K 0.09% 114
2022
Q3
$245K Buy
4,916
+10
+0.2% +$536 0.07% 121
2022
Q2
$273K Buy
4,906
+294
+6% +$16.3K 0.07% 119
2022
Q1
$256K Buy
+4,612
New +$237K 0.07% 127
2021
Q2
Sell
-1,758
Closed -$59K 255
2021
Q1
$59K Buy
+1,758
New +$62.6K 0.01% 159

Other funds holding NVO

Abundance Wealth Counselors's NVO Position: Q1 2026 in Review

Abundance Wealth Counselors sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,007 shares — an estimated $204K sold.

Abundance Wealth Counselors first reported a position in NVO in Q1 2021 and held it in 15 quarters. The position peaked at $490K in Q1 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Abundance Wealth Counselors reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Abundance Wealth Counselors sold 4,007 Novo Nordisk shares in Q1 2026, an estimated $204K.
  • Abundance Wealth Counselors first reported a position in Novo Nordisk in Q1 2021 and held it in 15 quarters.
  • Abundance Wealth Counselors's Novo Nordisk position peaked at $490K in Q1 2024.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Abundance Wealth Counselors's 13F filing for Q1 2026, filed 23 Apr 2026.